Rab 10 inhibitors represent a specialized class of chemical compounds that have garnered attention in the field of molecular biology and intracellular trafficking research. Rab 10, a member of the Ras-related GTPase family, is a protein involved in regulating vesicular transport and the dynamic movement of cellular membranes within eukaryotic cells. The term Rab 10 inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of Rab 10. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with Rab 10.
Rab 10 inhibitors typically function by interfering with the GTPase activity of Rab 10 or its interactions with downstream effector molecules, thereby affecting the regulation of intracellular vesicle trafficking and membrane dynamics. This interference can lead to alterations in various cellular processes, including endocytosis, exocytosis, and the overall maintenance of membrane organelles. Researchers employ Rab 10 inhibitors to gain insights into the physiological roles and molecular interactions of Rab 10 within cells, aiming to advance our understanding of the fundamental mechanisms involved in intracellular transport and membrane remodeling. Through the study of Rab 10 inhibitors, scientists seek to unravel the complexities of cellular logistics, membrane dynamics, and the broader field of cell biology, contributing to our knowledge of how cells precisely coordinate the movement and organization of intracellular structures to maintain cellular homeostasis and functionality.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis, which could decrease Rab10 expression by preventing mRNA transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, potentially reducing Rab10 protein levels by preventing translation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit transcription factors and may reduce Rab10 expression through suppression of gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and protein synthesis, which could reduce Rab10 levels as a downstream effect. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is a nucleotide analog that inhibits thymidylate synthase, affecting DNA replication and RNA transcription, potentially impacting Rab10 expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA and disrupts topoisomerase-II-mediated DNA repair, which could indirectly downregulate Rab10 mRNA synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises the pH of endosomes and lysosomes, which might interfere with normal trafficking and degradation pathways of proteins, including Rab10. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that could increase the half-life of proteins, potentially affecting Rab10 levels through altered protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor that may impact Rab10 expression by preventing the degradation of proteins that regulate Rab10 at a post-transcriptional level. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could affect signaling pathways that regulate Rab10 expression and membrane trafficking. | ||||||